Chase AIPricingFAQs
Display currency
Loading news…

Nimble Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Madison, Wisconsin, United States Founded 2019 11-50 employees For Profit

Nimble Therapeutics is bringing the power of massively parallel chemical synthesis to drug discovery.

Nimble Therapeutics was acquired by AbbVie in 2024 for $200M.
Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
28

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
10
IT spend
$486K

Company Info

Founded
2019
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
38
HQ
Madison, Wisconsin, United States
Region
Great Lakes, Midwestern US
Exit date
Dec 13, 2024

Signals & Scores

Heat score
Low
Trend (7d)
-0.2
Trend (30d)
-0.7
Trend (90d)
-1.6
Last leadership hire
Nov 30, 2022

Key People at Nimble Therapeutics

VP of Corporate Development
CEO
Chief Business Officer
Chief Scientific Officer
28
professional contacts at Nimble Therapeutics
Contact execs at Nimble Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Nimble Therapeutics

Loading news…

FAQs about Nimble Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Nimble Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments